Loading companies…
R
RheoCarti
Switzerland · Healthtech · Hardware
RheoCarti is developing titanium–hydrogel orthopedic implants designed to reproduce the low friction and shock absorption of natural joint cartilage.
A joint surface designed to behave more like cartilage
RheoCarti combines a load-bearing titanium structure with a cartilage-like hydrogel articulating surface. The design aims to reduce friction and absorb shock more like natural cartilage than conventional hard bearing surfaces. The company is developing hip resurfacing and total hip replacement implants, with a platform that could extend to other joints.
From laboratory work toward veterinary applications
The technology emerged from biomechanics and medical-device research at ETH Zurich. ETH’s Pioneer Fellowship description says the team is advancing from laboratory research toward preclinical validation, with veterinary hip replacement as an initial route toward use and later translation to human joint replacement. RheoCarti is therefore an implant-development company, not a marketed clinical product.
- Technology
- Titanium structure with hydrogel articulating surface
- Initial focus
- Hip resurfacing and total hip replacement
- Development stage
- Laboratory development toward preclinical validation
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Venture Kick support | CHF 150K | Venture Kick — Lead |
Investors
Venture KickLed Venture Kick supportCoverage
Sep 28, 2026RheoCarti · Venture Kick supportSimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
AventixAventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.€1.2M · Pre-seed